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Abstract  
The storage and transport of frozen cells underpins emerging/existing cell-based therapies and 
is used in every biomedical research lab globally. The current gold-standard cryoprotectant 
(DMSO) does not give quantitative cell recovery in suspension nor in 2D or 3D cell models 
and the solvent and cell debris must be removed prior to application/transfusion. There is a real 
need to improve this 50 year old method to underpin emerging regenerative and cell-based 
therapies. Here we introduce a potent and synthetically scalable polymeric cryopreservation 
enhancer which is easily obtained in a single step from the low cost and biocompatible 
precursor poly(methyl vinyl ether-alt-maleic anhydride). This polyampholyte enables post-
thaw recoveries of up to 88 % for a 2-D cell monolayer model compared to just 24 % using 
conventional DMSO cryopreservation. The polyampholyte also enables reduction of [DMSO] 
from 10 wt % to just 2.5 wt % in suspension cryopreservation, which can reduce the negative 
side-effects and speed up post-thaw processing. Post-thaw, the cells have reduced membrane 
damage and faster growth rates compared to those without the polymer. The polymer appears 
to function by a unique extracellular mechanism, by stabilisation of the cell membrane, rather 
than by modulation of ice formation and growth. This new macromolecular cryoprotectant will 
find applications across basic and translational biomedical science and may improve the cold-
chain for cell-based therapies. 
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Introduction 
Cryopreservation is an essential process for the long-term storage of cells and tissues. Red 
blood cells are the most frequently transfused blood product, with 12–16 million units 
transfused per year in the United States alone,1 but difficult processing has shifted the use of 
cryopreserved RBCs to settings only where their availability is limited.2 Leukaemia therapy is 
underpinned by the transfusion of (DMSO) cryopreserved hematopoietic stem cells, and 
mammalian cells are widely used in the biopharmaceutical industry for the production of 
recombinant therapeutic proteins (biologics).3 However, it is not currently possible or practical 
to supply this material reproducibly due to phenotypic changes of growing cultures, therefore 
the banking of these materials is essential.4 Additionally, the ability to preserve cells as 
monolayers, which can be readily used and do not need to be propagated forward, would be 
revolutionary in providing identical starting materials, for instance, ensuring precisely 
engineered reporter lines do not experience any sort of propagated “phenotypic drift” which 
would alter their precise reporting mechanisms.5 Furthermore, there is evidence that the core 
response of cells to cryopreservation is different if the cells are part of a network and the scale-
up of procedures from a microscopic cellular level to a macroscopic tissue scale will introduce 
new modes of injury specific to tissue freezing.6 Our monolayer results could pave the way to 
improve organ-on-a-chip preservation outcomes7 or perhaps even be the key to successful 
tissue preservation.   
The gold standard protocol for the (suspension) cryopreservation of mammalian cells is vial 
freezing in a solution containing 5-10 % of the cryoprotective agent (CPA) dimethyl sulfoxide 
(DMSO), which is able to enter cells and partly reduce injury by moderating the increase of 
solute concentration during freezing.8–10 Additionally, cells frozen in vials must be propagated 
forward through several passages before they are stable enough to be used for reproducible 
assays. While vial freezing in DMSO works for most cell lines, many are highly-sensitive to 
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DMSO.11 The ability to reliably store all cells and to employ lower concentrations of DMSO 
would aid multiple fields by increasing post-thaw viability and reducing processing. Compared 
to freezing in solution, DMSO does not work well for cell monolayers,12 typically resulting in 
only around 20 – 35 % cell recovery.13,14 Clearly, there exists a real need to transform our 
approach to cryopreservation, in order to boost cell recovery, function, and reduce the 
processing challenges. 
Despite the above cryopreservation challenges, extremophiles have evolved in nature to allow 
survival at sub-zero conditions by both promoting and/or inhibiting the formation and growth 
of ice, presenting major opportunities for biomedicine. In addition to these strategies, 
extremophiles use the production of osmotic protectants such as trehalose,15–17 proline,18–21 and 
sucrose,22 as well as macromolecules such as antifreeze proteins,23,24 or late embryogenesis 
abundant proteins (LEAs).25 Synthetic polymers, which mimic antifreeze proteins’ ice 
recrystallisation inhibition (IRI) properties, have emerged in recent years as promising 
cryoprotectants.26–28 Ice recrystallisation during thawing is a major cause of cell death, and IRI 
active polymers such as poly(vinyl alcohol) can lead to increases in post-thaw yield.29 
Poly(proline), which displays moderate IRI, has been shown to improve post-thaw recovery of 
cell monolayers, potentially by interacting with cell membranes as well as its IRI.30 These 
examples show that macromolecular cryoprotectants can be designed to modulate membrane 
stability as well as ice growth, presenting an exciting opportunity. Carboxylated poly(lysine), 
and other synthetic poly(ampholytes) bearing mixed positive and negative charges can interact 
with cell membranes and have been evaluated in cryovial vitrification31, monolayer slow-
vitrification32, or slow-freezing in cryovials33 but never slow-freezing of monolayers. These 
result in good post-thaw recoveries but require, for example, 6.5M ethylene glycol solutions 
and often very fast cooling rates,32 as well as the issue of removing such a high concentration 
of solvent from the cells before toxicity occurs. They are also not synthesised on a large scale, 
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necessary for a step-change in how cryopreservation is conducted, and hence they have not 
been widely adopted.  
Despite the above progress, the actual cell yields obtained with poly(ampholytes) can still be 
low, and often require vitrification (formation of an ice-free state using very high solvent 
loads), which is not typically practical for most cellular cryopreservation settings. An ideal 
polymeric cryoprotectant would increase cell yield post-thaw, be easily removed, available on 
a commercial scale for wide use, enable monolayer as well as suspension cell cryopreservation, 
and enhance the cryopreservation of all cell types with minimal re-formulation requirements.  
Here we report a poly(ampholyte) cryopreservative that significantly enhances the post-thaw 
cell yield of a broad range of cell types including nucleated and anucleated cells in suspension 
and as monolayers under slow freezing conditions. The polymer is easily obtained from a 
clinically used, low cost, precursor which ensures scalability. Additionally, it appears that the 
polymer externally protects cell membranes during freezing as its main mode of action, rather 
than ice growth modulation, and since it does not enter the cells, it is easily removed.  We also 
demonstrate that the DMSO concentration required can be reduced as low as 2.5 wt % through 
the use of a higher concentration of polymer. 
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Methods and Materials 
 
Materials.  Phosphate-buffered saline (PBS) solutions were prepared using pre-formulated 
tablets (Sigma-Aldrich) in 200 mL of Milli-Q water (>18.2 Ω mean resistivity) to give [NaCl] 
= 0.138 M, [KCl] = 0.0027 M, and pH 7.4.  Poly(methyl vinyl ether-alt-maleic anhydride) Mn 
80,000 and 311,000 g.mol-1, dimethylaminoethanol and N-[4-(aminomethyl)benzyl]rhodamine 
6G-amide bis(trifluoroacetate) were purchased from Sigma-Aldrich. Poly(methyl vinyl ether-
alt-maleic anhydride) average Mn 20,000 g.mol-1 was purchased from Scientific Polymer 
Products, the dispersity of polymer P2 from the manufacturer is 2.7, P3 is 3.47; the supplier of 
P1 does not list the Mw value, only the Mn. Sodium chloride was purchased from Fisher 
Scientific. All solvents were purchased from VWR or Sigma Aldrich and reagents were used 
without further purification unless indicated.  
 
Note on the choice of polymer:  Dimethylamino functionality was selected for the cationic 
component. This was driven by our previous observations on the role of hydrophobicity on ice 
crystal growth, that ethyl and propyl modifications gave lower activity.34 Secondly, there were 
solubility reasons; When more hydrophobic pendant groups are installed [diethyl and 
diisopropyl] dissolution becomes an issue, with these samples having limited solubility at 
concentrations greater than 20 mg.mL-1. For these polymers to be practical in a lab, 
concentrations stocks need to be made, meaning that concentrations of at least 2 x what is 
required for cryopreservation must be achieved. The dimethyl amino gave this balance.  
 
Synthesis of Polyampholytes.  As a representative example, poly(methyl vinyl ether-alt-
maleic anhydride), average Mn ~80,000 Da, (1 g) was dissolved in tetrahydrofuran (50 mL) 
and heated to 50 °C with stirring. After dissolution, dimethylamino ethanol (2 g) was added in 
excess, forming a pink waxy solid, which was allowed to stir for 30 minutes. 50 mL water was 
added, and the reaction left to stir overnight followed by purification in dialysis tubing 
(Spectrapor, 12 – 14 kDa MWCO) for 48 hours with 7 water changes. The resulting solution 
was freeze-dried to evolve a white solid. 
1H NMR (DMSO): δ = 2.30 – 2.80 (CH2CH(OCH3)CH2, br), 2.42 ((CH3)2NCH2, s, 6H), 2.50 
(CH2CH(OCH3)CH2, s, 3H), 2.66 (NCH2CH2COO, t, 2H), 3.02 – 3.37 (CH2CH(OCH3)CH2), 
3.41 – 4.48 (CH(OCH3)CH(COOH)CH(COOC), CH(OCH3)CH(COOH)CH(COOC), br), 3.56 
(NCH2CH2COO, t, 2H). 13C NMR (DMSO): 42 ((CH3)2NCH2), 55 (NCH2CH2COO), 58 
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(NCH2CH2COO). IR: 1220 cm-1 (C-O), 1342 (C-N), 1560 (O=C-O- Carboxylate), 1724 (C=O), 
2364 (Me2N-H+ ammonium). 
 
Synthesis of Fluorescently Labelled Polyampholytes.  As a representative example, 
poly(methyl vinyl ether-alt-maleic anhydride), average Mn ~80,000 Da, (300 mg) was 
dissolved in tetrahydrofuran (50 mL) and heated to 50 °C with stirring. After dissolution, N-
[4-(aminomethyl)benzyl]rhodamine 6G-amide bis(trifluoroacetate) (3 mg) and triethylamine 
(10 mg) were added and left for 20 minutes before dimethylamino ethanol (2 g) was added in 
excess, forming a pink waxy solid, which was allowed to stir for 30 minutes. 50 mL water was 
added, and the reaction left to stir overnight followed by purification in dialysis tubing 
(Spectrapor, 12 – 14 kDa MWCO) for 48 hours with 7 water changes. The resulting solution 
was freeze-dried to evolve a white solid.  
 
Physical and Analytical Methods.  1H and 13C NMR spectra were recorded on Bruker Avance 
III HD 300 MHz, HD 400 MHz or HD 500 MHz spectrometers using deuterated solvents 
obtained from Sigma-Aldrich. Chemical shifts are reported relative to residual non-deuterated 
solvent.  
 
Ice Recrystallisation Inhibition Assay. Ice wafers were annealed on a Linkam Biological 
Cryostage BCS196 with T95-Linkpad system controller equipped with a LNP95-Liquid 
nitrogen cooling pump, using liquid nitrogen as the coolant (Linkam Scientific Instruments 
UK, Surrey, UK). An Olympus CX41 microscope equipped with a UIS-2 20x/0.45/∞/0-
2/FN22 lens (Olympus Ltd, Southend on sea, UK) and a Canon EOS 500D SLR digital camera 
was used to obtain all images. Image processing was conducted using Image J, which is freely 
available from http://imagej.nih.gov/ij/. LogP was calculated from the hydrophobicity of the 
pendant group using ChemDraw Professional 16.0. 
IRI evaluation. A 10 µL droplet of polymer in PBS solution was dropped from 1.4 m onto a 
glass microscope coverslip, on top of an aluminium plate cooled to -78 °C using dry ice. The 
droplet freezes instantly upon impact with the plate, spreading out and forming a thin wafer of 
ice. This wafer was then placed on a liquid nitrogen cooled cryostage held at -8 °C. The wafer 
was then left to anneal for 30 minutes at -8 °C. The number of crystals in the image were 
counted, again using ImageJ, and the area of the field of view divided by this number of crystals 
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to give the average crystal size per wafer, and reported as a percentage of area compared to 
PBS control. 
 
Differential scanning calorimetry (DSC).  Samples were prepared by weighing standard 40 
μL aluminium pans and lids (Mettler Toledo, Leicestershire, UK) and adding 20 μL of solution 
before hermetically sealing and reweighing in order to quantify the exact mass of sample.  Each 
sample was then transferred to a liquid nitrogen cooled DSC 1 STAR® system (Mettler 
Toledo) differential scanning calorimeter. The mass of the aluminium pan and sample mass 
was input into the complimentary STARe thermal analysis software to retain a digital record 
and aid analysis. 
Freezing and thawing of DSC samples and evaluation of DSC spectra.  Each DSC sample was 
individually cooled from +25 ºC to -150 ºC at a rate of 10 ºC.min-1 while concurrently 
monitoring the heat flow (mW) of the system to detect any endothermic or exothermic 
transitions. When samples reached -150 ºC, each sample was held for 10 min, then warmed at 
a rate of 10 ºC.min-1 from -150 ºC to +25 ºC. 
 
Blood Testing Protocol. 10 mL Sheep blood in Alsevers solution was added to a 15 mL 
centrifuge tube and centrifuged at 2000 rpm for 5 m to concentrate the solution, 7 mL of the 
supernatant was removed and replaced with 7 mL PBS solution. Polymer solutions were made 
at 2X the required concentration to ensure the correct final cryoprotectant concentration. 0.5 
mL of the blood solution was added to 0.5 mL of the polymer solutions in 2 mL cryovials. 
These were then incubated in the fridge for 30 m before freezing above liquid nitrogen vapour. 
After 1 h, samples were thawed in a water bath at 45 °C for 10 m, after which they were 
transferred to Eppendorf tubes and centrifuged at 2000 rpm for 5 m. 40 µL of the supernatant 
was removed and added to 750 µL of AHD solution. After vortexing, the samples were pipetted 
into a 96 well plate in triplicate (3 x 200 µL per sample) and the absorbance recorded at 580nm 
in the BioTek plate reader. Samples were compared against unfrozen PBS and lysis buffer 
samples as the 0 and 100% lysis samples respectively.  
 
Cell Culture. Human Caucasian lung carcinoma cells (A549) were obtained from European 
Collection of Authenticated Cell Cultures (ECACC) (Salisbury, UK) and grown in 175 cm2 
cell culture Nunc flasks (Corning Incorporated, Corning, NY). Standard cell culture medium 
was composed of Ham's F-12K (Kaighn's) Medium (F-12K) (Gibco, Paisley, UK) 
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supplemented with 10% USA-origin fetal bovine serum (FBS) purchased from Sigma Aldrich 
(Dorset, UK), 100 units∙mL-1 penicillin, 100 µg∙mL-1 streptomycin, and 250 ng∙mL-1 
amphotericin B (PSA) (HyClone, CramLington, UK). Mouse calvarial osteoblastic cells (MC-
3T3) were obtained from ECACC and grown in 75 cm2 cell culture Nunc flasks.  Standard cell 
culture medium was composed of Minimum Essential Medium α (Gibco) supplemented with 
10% USA-origin fetal bovine serum (FBS), 100 units∙mL-1 penicillin, 100 µg∙mL-1 
streptomycin, and 250 ng∙mL-1 amphotericin B (PSA).  Mouse brain neuroblastoma cells 
(Neuro-2a) were obtained from American Tissue Culture Collection (ATCC) (Middlesex, UK) 
and grown in 75 cm2 cell culture Nunc flasks.  Standard cell culture medium was composed of 
Eagle’s Minimum Essential Media (EMEM) (Gibco) supplemented with 10% USA-origin fetal 
bovine serum (FBS), 100 units∙mL-1 penicillin, 100 µg∙mL-1 streptomycin, and 250 ng∙mL-1 
amphotericin B (PSA).  All cells were maintained in a humidified atmosphere of 5% CO2 and 
95% air at 37 °C and the culture medium was renewed every 3–4 days. The cells were 
subcultured every 7 days or before reaching 90% confluency. To subculture, cells were 
dissociated using 0.25% trypsin plus 1 mM EDTA in balanced salt solution (Gibco).  A549 
cells were reseeded at 1.87∙105 cells per 175 cm2 cell culture flasks.  MC-3T3 cells were 
reseeded at 1.87∙105 cells per 75 cm2 cell culture flasks.  Neuro-2a cells were reseeded at 
7.5∙104 per 75 cm2 cell culture flasks. 
 
Cell Solution Preparation.  Solutions for cell incubation experiments were prepared by 
dissolving the individual compounds in base cell media supplemented with 10% FBS and 1x 
PSA (solutions used as freezing buffers did not contain PSA) and sterile filtered prior to use.  
 
Cytotoxicity Screening.   
Polyampholyte cytotoxicity.  A549 cells were seeded at 4∙104 cells per well in 200 μL of cell 
culture medium with indicated concentrations of polyampholyte in 96-well plates 
(ThermoFisher). Cells were incubated with polymer for 10 m and exchanged against completed 
cell media or incubated with polymer for 24 h in a humidified atmosphere of 5% CO2 and 95% 
air at 37 °C. Following the incubation period, resazurin sodium salt (Sigma Aldrich) was 
dissolved in phosphate buffered saline (PBS) (Sigma Aldrich) and added to wells in an amount 
of 1/10th initial well volume.  Readings were taken using the Synergy HTX Multi-Mode Reader 
(BioTek, Swindon, UK) at 570/600 nm absorbance every 30 m until control cells reached ~70% 
reduction.  
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DMSO cytotoxicity.  A549 cells were seeded at 1∙104 cells per well in 100 μL of cell culture 
medium with indicated concentrations of DMSO in 96-well plates.  Cells were incubated for 
30 m in a humidified atmosphere of 5% CO2 and 95% air at 37 °C. After 30 m the media was 
exchanged for fresh cell media and a resazurin sodium salt assay was performed as described 
previously.  Values were normalized by dividing experimental values by control values 
 
 
Membrane Kinetics. Methods adapted from Su35.  A549 cells were dissociated and incubated 
with 1 µM of calcein-AM (BD Biosciences, Workingham, UK) in completed cell media for 30 
m at 37 °C with frequent mixing.  Cells were then centrifuged and rinsed twice with media.   
Cells were plated at a density of 4∙105 in 100 µL in 96-U-well suspension plates (Sarstedt Ltd., 
Leicester, UK) and centrifuged at 500 rpm for 2 m.  Experimental solutions of 50 µL were 
added at 4x and 50 µL of 0.32% trypan blue was added for a final concentration of 0.08%.  
Plate was placed in the BioTek plate reader at 37 °C and read every 10 m at 494/517 nm for 4 
h.  Plate was then imaged with the CKX41 microscope with LED illumination, the XC30 
camera, and processed using the CellSens software. 
 
Live/Dead Staining of Polyampholyte Incubation.  A549 cells seeded at 4∙105 cells per well 
in 500 µL of cell culture medium in 24-well plates.  Cells were incubated with polymer for 24 
h in a humidified atmosphere of 5% CO2 and 95% air at 37 °C.  Following the 24 h incubation, 
cells were incubated with 0.3 µM calcein (ThermoFisher) and 10 µM ethidium homodimer-1 
(ThermoFisher) in PBS.  Cells were incubated at room temperature for 45 m.  Stain solution 
was removed and wells were washed twice with PBS.  Plate was read using the BioTex plate 
reader at 494/517 nm and 528/617 nm.  Plate was then imaged with the CKX41 microscope 
with pE-300-W LED illumination, the XC30 camera, and processed using the CellSens 
software. 
 
Cryopreservation of Cell Suspensions.  A549 cells for suspension freezing were removed 
from adherent culture by treatment with 0.25% trypsin plus 1 mM EDTA in balanced salt 
solution for 5 m in a humidified atmosphere of 5% CO2 and 95% air at 37 °C. The number of 
viable cells was determined by counting with a hemocytometer (Sigma Aldrich) at room 
temperature after 1:1 dilution of the sample with 0.4% trypan blue solution (Sigma Aldrich). 
The cell density was adjusted to obtain a cell suspension of 1∙105 cells∙mL-1. Solutions 
containing the poly(ampholyte) were prepared at 2X the final concentration in F12-K media 
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containing 20% FBS and 2X the indicated concentration of dimethyl sulfoxide (DMSO). 500 
µL cell suspension and 500 µL freezing solution was added to individual cryovials (2 mL, 
Nalgene®, Thermo Scientific, NY) and mixed three times with a 1000 µL pipette. Final 
concentration of FBS in freezing solutions was 10%. Cryovials were placed in a CoolCell® 
LX freezing container (BioCision, LLC, Larkspur, CA), and transferred to a -80 °C freezer 
where they were frozen at a rate of 1 °C∙min-1. After 2 h at -80 °C, vials were transferred to the 
vapour phase of a liquid nitrogen dewar at -196 °C for 24 h. After 24 h at -196 °C, cells were 
rapidly thawed by placing the vials in a foam support in a water bath set to 37 °C. The contents 
of each vial were added to 9 mL complete F-12K media and centrifuged at 2 g for 5 m to pellet 
cells. The supernatant was discarded and the cell pellet was resuspended in 500 µL complete 
cell media then transferred to individual wells of a 24-well plate (Corning Incorporated, 
Corning, NY). Cells were placed in a humidified atmosphere for 24 h and then dissociated 
using 0.25% trypsin plus 1 mM EDTA in balanced salt solution. The number of viable cells 
was then determined by counting with a hemocytometer at room temperature after 1:1 dilution 
of the sample with 0.4% trypan blue solution. The initial cell medium was discarded such that 
any non-attached cells were not included in the assessment.  The percentage of recovered cells 
was calculated by dividing the number of cells with intact membranes after freezing and 
thawing by the number of cells initially frozen, multiplied by 100. 
 
Cryopreservation of Cell Monolayers.  Methods adapted from Bailey14.  A549 cells to be 
frozen in the monolayer format were seeded at 4∙105 cells per well in 500 µL of cell culture 
medium in 24-well plates.  MC-3T3 and Neuro-2a cells to be frozen in the monolayer format 
were seeded at 5∙105 cells per well in 500 µL of cell culture medium in 24-well plates (Neuro-
2a cells were frozen on collagen coated plates). Plates had a total available volume of 3.4 mL 
with an approximate growth area of 1.9 cm2, no coverslips were used and plates were used with 
the accompanying lid.  Cells were allowed to attach to the entire free surface of the bottom of 
the well and formed a confluent layer not greater in height than one cell. Before experimental 
treatments, cells were allowed to attach for 2 h to the plates in a humidified atmosphere of 5% 
CO2 and 95% air at 37 °C. The medium was exchanged against fresh medium to remove all 
unattached cells and then incubated for 24 h in a humidified atmosphere of 5% CO2 and 95% 
air at 37 °C. Following the incubation period, the culture medium was removed and cells were 
exposed for 10 m at room temperature to different concentrations of solutes dissolved in base 
media supplemented with 10% FBS and the indicated concentrations of dimethyl sulfoxide 
(DMSO).  After 10 min, the freezing solutions were removed and the plate placed inside a 
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CoolCell® MP plate (BioCision), transferred to a -80 °C freezer and frozen at a rate of 1 
°C∙min-1. After 24 h at -80 °C, cells were rapidly thawed by addition of 500 µL cell culture 
medium warmed to 37 °C.  Cells were placed in a humidified atmosphere for 24 h and then 
dissociated using 0.25% trypsin plus 1 mM EDTA in balanced salt solution. The number of 
viable cells was then determined by counting with a hemocytometer at room temperature after 
1:1 dilution of the sample with 0.4% trypan blue solution. The initial cell medium was 
discarded such that any non-attached cells were not included in the assessment.  The percentage 
of recovered cells was calculated by dividing the number of cells with intact membranes after 
freezing and thawing by the number of cells present prior to freezing (i.e. after application of 
pre-treatments), multiplied by 100. 
Collagen plate coating.  Collagen I from rat tail (Sigma-Aldrich) was diluted to 50 µg∙mL-1 in 
200 mM acetic acid (Sigma) and added to each well of the cell culture plate at 5 µg collagen∙cm-
2. Plates were incubated with the dissolved collagen for 1 h and after this incubation period the 
collagen solution was removed and the plates were rinsed three times with 200 µL PBS to 
remove any residual acetic acid solution. The collagen treated plates were allowed to dry for 1 
h in a laminar flow hood and stored for less than 1 week at 4 °C prior to use. 
 
Post-Freeze Viability.  A549 cells were cryopreserved as previously indicated.  After 
dissociation and counting, cells were plated at a density of 1.25∙104 per well in a 6-well plate 
(ThermoFisher).  For low yield recovery, multiple freezing wells were combined to provide an 
adequate number of cells.  Control cells were plated at the same density with no prior 
manipulation.  Cells were incubated in a humidified atmosphere of 5% CO2 and 95% air at 37 
°C for the indicated number of days and then dissociated using 0.25% trypsin plus 1 mM EDTA 
in balanced salt solution for counting.  Cell media was replaced on day four with fresh media.  
Growth rates were calculated by dividing the number of cells present by the initial plating 
density.   
 
Post-Freeze Membrane Permeability.  A549 cells were cryopreserved as previously 
indicated.  Following the 24 h post-thaw incubation, cells were incubated with 0.3 µM calcein 
and 10 µM ethidium homodimer-1 in PBS.  Cells were incubated at room temperature for 45 
min.  Stain solution was removed and wells were washed twice with PBS.  Plate was read using 
the BioTex plate reader at 494/517 nm and 528/617 nm.  Plate was then imaged with the 
CKX41 microscope with pE-300-W LED illumination, the XC30 camera, and processed using 
the CellSens software. 
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Statistical Analyses.  Data were analysed with a one-way analysis of variance (ANOVA) on 
ranks followed by comparison of experimental groups with the appropriate control group 
(Holm–Sidak method) followed by Tukey’s post hoc test. Excel 2013 (Microsoft, Redmond, 
WA) and R (R Foundation for Statistical Computing, Vienna, Austria) were used for the 
analyses and graphs.  Data sets are presented as mean ± (SEM).   
 
 
Results 
Poly(methyl vinyl ether-alt-maleic anhydride) Mn = 20 kDa (P1), 80 kDa (P2), and 311 kDa 
(P3) was selected as the precursor to a poly(ampholyte) as it is produced on multi-ton scales, 
and is safe as both a food additive and bio-adhesive.36 The anhydride was ring-opened by 
addition of dimethylamino ethanol to give a poly(ampholyte) of appropriate hydrophobicity 
and solubility34 (Figure 1a, characterization data shown in Figure S1). Other, more 
hydrophobic, amine substituents result in less soluble materials and the dimethyl was found in 
screening to provide the best balance. By using an anhydride precursor we guarantee the 1:1 
ratio of cationic/anionic groups and regioregularity, not obtainable by other co-polymerization 
methods. Ice recrystallisation inhibition (IRI) assays37 (where smaller ice crystals indicate more 
activity) showed that P1-P3 had only weak, molecular weight dependant, IRI activity (Figure 
1b), below that of other poly(ampholytes).34,38 For reference, type I antifreeze protein, used as 
a positive control, leads to < 20 % mean grain size at < 1 mg.mL-1 concentrations (Figure S2) 
and hence the poly(ampholytes) can be considered to be very weakly IRI active when 
discussing mechanisms of cryopreservation (below).  DSC (differential scanning calorimetry) 
confirmed ice crystallisation in the presence of P2, thus ruling out non-colligative effects.The 
small differences in the enthalpy of crystallisation are what we would expect due to solute 
concentration effects on freezing point depression39, and showing vitrification (an entirely 
different cryopreservation approach where a glass is formed instead of ice31,32) is not occurring 
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(Figure 1c). Full DSC traces and onset melting temperatures are shown in Figure S3 and S4 
respectively.  As there is only weak IRI activity, any emergent cryoprotectant properties (vide 
infra) can be correlated to unique cellular interactions, such as with the cell membrane.40 
 
 
Figure 1. Polymer synthesis and ice activity. a) Synthesis of poly(ampholyte)s used. b) Ice 
recrystallisation inhibition assay of P1-P3. MGS = mean ice grain size compared to a PBS 
control after 30 min of annealing at – 8 °C. Error bars represent ±SEM of 3 repeats. c) Enthalpy 
of crystallisation (proportional to ice volume) for cryopreservation solutions containing P2 (NP 
= no polymer) via differential scanning calorimetry at a cooling rate of 1 °C.min-1. (N = 24, P 
= 0.0000000004, * P < 0.001 from NP w/0% DMSO, ** P < 0.001 from NP w/10% DMSO).  
Error bars represent ±SEM of 3 repeats. 
 
Erythrocyte cryopreservation was first used as a simple cellular screening model for membrane 
damage/stabilisation.41 Figure 2a shows that 100 mg.mL-1 (~10 wt %) of all molecular weights 
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of poly(ampholytes) gave > 60 % recovery, higher than what is achieved for IRI active 
polymers42 alone (such as PVA, Figure S5) showing this unique material does not function 
(primarily) by ice-growth modulation. Higher concentrations could not be tested due to the 
solubility limits of the polymer, which is prepared at two fold concentration. The recovery 
levels here are comparable to those using 20 – 40 wt % glycerol, which also requires extensive 
post-thaw washing resulting in significant cell loss.28,43,44 P2 was found to be the most potent 
molecular weight of cryoprotectant, giving > 80 % recovery compared to longer/shorter 
polymers, and erythrocytes frozen in P2 also showed slightly less osmotic fragility than 
unfrozen controls (Figure S6). The post-thaw recovery values utilizing 100 mg.mL-1 P2 were 
also independent of pre-freeze incubation time/temperature (Figure 2b), in stark contrast to 
glycerol, which needs carefully controlled addition/removal to reduce toxicity and maximise 
recovery and introduces processing challenges which are overcome in this polymeric 
system.45,46 It should be noted that addition of uncharged water soluble macromolecules often 
reduces post-thaw haemolysis for erythrocytes (such as glycerol and PVP (Figure S5)), and the 
key aim here was to ensure the material was suitable for cryopreservation and these results 
were utilized for primary screening to ensure compatibility before progressing to nucleated 
cells (below).  
 
Figure 2. Red blood cell post-thaw recovery [defined as (1-haemolysis(*100))] with 
cryoprotective polymers.  a) RBC frozen rapidly to – 196 ºC/thaw 45 ºC.  b) Effect of pre-
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freezing incubation time and temperature on post-thaw recovery with 100 mg.mL-1 P2. 
Incubation time (0, 15 min, 30 min, 24 h), incubation temperature (4 ºC or 23 ºC), freezing 
conditions (directly submerged (direct) or in vapour (vapour) of liq. N2). All error bars 
represent ± SEM from a minimum of 3 repeats. 
 
Mammalian cell monolayer freezing is significantly more challenging than suspension 
freezing13 but is important for regenerative medicine, biotechnology, and basic research 
applications and was hence chosen as a robust challenge.47 Confluent monolayers of A549 
(epithelial lung carcinoma) cells were selected to screen for cryopreservation, using the 
polymer as a supplement to DMSO to increase recovery, which is already low (see data below). 
A549 cells were cryopreserved at 1 °C.min-1 to – 80 °C, following a 10 min incubation with 
10 wt % DMSO containing a concentration gradient of P2 or PVA. PVA was used as it is a 
potent IRI and has been reported to enhance cell recovery by inhibiting ice recrystallisation 
and hence enables us to compare the utility of this new material but also mechanisms of action, 
as P2 is not a potent IRI.48 The cells were subsequently thawed, allowed to recover for 24 h, 
and the total cell yield determined (Figure 3b). [Note: it is crucial to allow 24 h post-thaw 
incubation as shorter periods give false positive results and over-estimate cell recovery.13] The 
addition of 40 mg.mL-1 P2 resulted in > 4 fold increase in recovered cells (89 %) compared to 
DMSO alone (20 %). Lower concentrations of P2 also gave significant cell recovery with just 
1 mg.mL-1 giving a 2.5 fold increase, which is remarkable for such a dilute additive and 
outperforms other cryopreservative polymers.30–32 PVA, which has been shown to protect cells 
in solution during cryopreservation,29 was less effect in the preservation of monolayers.  Cells 
frozen in cryovials are in a large quantity of solution, which may make IRI activity the most 
important damaging factor, whereas cells frozen as monolayers exist in only a small liquid 
layer, therefore the benefit of IRI may not be sufficient for the protection of monolayers. These 
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results support our hypothesis that P2 is a unique polymer cryoprotectant which surpasses the 
performance of previously reported materials and may function by a unique mechanism. 
Molecular weight effects of the polymer were also screened, with P2 found to outperform P1 
and P3 in this cryopreservation system, but all can be considered very potent cryoprotectants 
(Figure 3c). 
Two additional mammalian cell lines, Neuro-2a and MC-3T3, were also explored. DMSO 
cryopreservation alone gave < 20 % cell recovery, as these cells appear more delicate than the 
(robust) A549 line and avenues to fine-tune the recoveries of these cells exist, as it may simply 
be the osmolarity for these formulations is too high, as hyperosmotic stress has been implicated 
in cell cycle arrest, DNA damage, oxidative stress, inhibition of transcription and translation, 
and mitochondrial depolarization49 and is a known consequence of cryopreservation.50 
However, supplementing P2 gave a 3-fold enhancement in post-thaw cell recovery in both 
cases (Figure 3d), showing that more fragile cells will also respond well to this new 
cryoprotectant. We summarise the fold-increase in post-thaw recovery compared to 10 % 
DMSO alone for all the cell lines in Figure 3E, demonstrating the universal applicability of our 
new material.  
Cytotoxicity testing of P2 revealed no decrease in cell viability for short exposure times, which 
are used in our cryopreservation protocol (as excess solution is removed before freezing) and 
were all less cytotoxic than DMSO (Figure 3f). A 24 h incubation, as a means of extreme stress 
outside our protocol, was conducted to exaggerate any effects and to provide mechanistic 
insight. Above 20 mg.mL-1, 24 h incubation reduced cell metabolism and microscopy 
suggested membrane perturbations for long exposure times (Supp Info, Figure S7) which 
guided further investigations into how these polymers function (vide infra).  
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Figure 3. Cell monolayer cryopreservation and cytotoxicity. Recovered cells counted by 
trypan blue exclusion assay relative to unfrozen controls. All cells cryopreserved for 24 h 
at -80 °C, then 24 h post-thaw incubation. a) Schematic of cryopreservation/thawing protocol; 
b) Post-thaw cell recovery (as % of unfrozen controls) of A549 cells cryopreserved with 10 % 
DMSO plus variable concentrations of P2 or PVA (NP = no polymer) (N = 39, P = 
0.000000002, * P < 0.001 from NP w/10% DMSO).  The data represent the mean ± SEM of 3 
independent experiments with 2 nested replicates each.  c) Effect of polymer molecular weight 
(P1 – P3, NP = no polymer) and concentration on A549 cell recovery (N = 42, P = 0.000006, 
* P < 0.001 from NP w/10% DMSO). The data represent the mean ± SEM of 3 independent 
experiments with 2 nested replicates each.  d) Post-thaw recovery of Neuro-2a and MC-3T3 
cells after cryopreservation with 10 % DMSO plus variable concentrations of P2. The data 
represent the mean ± SEM of 4 independent experiments with 2 nested replicates each (Neuro-
2a: N = 28, P = 0.0005, * P < 0.001 from Neuro-2a w/0 mg.mL-1 P2; MC-3T3: N = 28, P = 
0.02, * P < 0.01 from MC-3T3 w/0 mg.mL-1 P2). e) Fold (relative to 10 % DMSO) post-thaw 
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recovery for all cell lines as a function of P2 concentration. f) Cytotoxicity of P2 against A549 
cells, incubation time is 10 min or 24 h (N = 48, P = 0.0000000001, * P < 0.001 from 0 mg.mL-
1 P2). The data represent the mean ± SEM of 3 independent experiments. 
 
In addition to the (major) challenge of cell monolayer freezing, suspension cryopreservation is 
also challenging for cells that cannot tolerate the high (10 wt %) concentrations of DMSO, 
which has been shown to cause downstream toxicity after just 30 min of exposure (Figure S8).  
We therefore explored if P2 could rescue post-thaw cell recovery when used at DMSO 
concentrations which are normally too low to enable cryopreservation. A549 suspension 
freezing showed that supplementing P2 to 10 wt % DMSO did not enhance recovery of 
suspension cells, suggesting a ceiling for total recovery and distinct to the monolayer results 
(highlighting the challenge of cryopreservation). However, adding 20 mg.mL-1 P2 allowed 
DMSO reduction down to 5 wt %, and even 2.5 wt %, with cell recovery levels being 
comparable to 10 wt % DMSO with no polymer (Figure 4a). The ability to lower DMSO to 2.5 
%, with the addition of P2, and retain recoveries similar to 10 wt % DMSO is a remarkable 
finding and will permit the cryopreservation of cells incapable of tolerating high concentrations 
of DMSO. Additionally, the ability to drastically lower DMSO could permit higher recoveries 
and allow, for example, a larger amount of human peripheral blood progenitor cells to be 
infused to patients.51  For A549 cells frozen as monolayers, we found that 40 mg.mL-1 P2 
provided significant cell recovery at 5 wt % DMSO, demonstrating the potent cryopreservative 
properties of this macromolecular polymer. It was also observed that a reduction in DMSO to 
5 wt %, combined with 5 mg.mL-1 P2 enabled recovery similar to polymer-free 10 % DMSO 
and also comparable to even lower DMSO at 2 wt % with 40 mg.mL-1 P2 (Figure 4b). The 
importance of this cannot be understated as lowering DMSO (whilst retaining cell yield) will 
dramatically increase the availability of cells for regenerative medicine, reduce downstream 
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toxicology challenges, and enable the storage of cells which cannot tolerate higher DMSO. For 
comparison, other poly(ampholytes) reported for cryopreservation required a complex, high 
organic solvent content solution of 6.5M ethylene glycol (~ 40 wt %), 0.5 M sucrose (~ 15 wt 
%) as well as 10 wt % of polymer to obtain a similar result32 or only gave cell yields below 
that of DMSO alone,52 highlighting the unique potency of the present system.  
 
 
Figure 4. A549 variable DMSO/P2 suspension and monolayer cryopreservation. 
Recovered cells counted by trypan blue exclusion assay relative to unfrozen controls. 
Suspension cells cryopreserved for 24 h at -196 °C, monolayer cells cryopreserved for 24 h at 
-80 °C, both methods incubated 24 h post-thaw. a) Impact on suspension post-thaw recovery 
of varying DMSO and P2 concentrations (NP = no polymer) (N = 90, P = 0.0000000001, * P 
< 0.001 from NP w/10% DMSO). The data represent the mean ± SEM of at least 3 independent 
experiments. b) Impact on monolayer post-thaw recovery of varying DMSO and P2 
concentrations (NP = no polymer) (N = 60, P = 0.0000000001, * P < 0.001 from NP w/10% 
DMSO). The data represent the mean ± SEM of 3 independent experiments with 2 nested 
replicates each. 
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While membrane integrity post-thaw is a general measure of cell survival, it does not provide 
any insight into long-term damage. Thus a 6 day growth assay was conducted to evaluate cell 
function. Post-thaw proliferation rates of A549 cells, which had been cryopreserved in a 
monolayer format with/without P2, were measured and compared to unfrozen control cells 
seeded at an identical density (Figure 5a). Cells cryopreserved with 10 mg.mL-1 P2 recovered 
at equal or faster rates than those in 10 % DMSO alone, but 40 mg.mL-1 gave slower growth 
rates than 10 mg.mL-1. Therefore, 10 mg.mL-1 can be considered the optimum formulation for 
this format and cell line to ensure high yield and retention of function. As membrane interaction 
and stabilization is a potential mechanism of action, supported by the erythrocyte observations 
(Supp Info, Figure S6), membrane permeation post-thaw was also assessed. The ethidium 
homodimer-1 (EhtD-1)/calcein-AM stains (LIVE/DEAD assay) were used. Healthy cells 
internalize calcein-AM and convert it to calcein, which then fluoresces green; EthD-1 passes 
though damaged membranes to nuclei where it brightly fluoresces red. Cells previously 
cryopreserved in 10 % DMSO had significant numbers of compromised membranes, but in 
contrast, addition of P2 lead to far fewer red nuclei, supporting the hypothesis that P2 stabilizes 
the cell membranes during freeze/thaw cycles (Figure 5b), graphical values are shown in Figure 
S9. Poly(ampholytes) are known to interact with model phospholipid membranes to a greater 
extent than other zwitterions such as poly(sulfobetaines)40 and we have shown that 
poly(ampholyte)s do not offer any stabilization to prokaryotes which have markedly different 
phospholipid compositions, supporting a specific membrane interaction.53  
To visualize uptake or cell binding, a rhodamine 6G tagged poly(ampholyte) (confirmed in 
Figure S10) was synthesized and exposed to A549 cells for both 10 min and 24 h. Confocal 
microscopy revealed no polymer-associated intracellular or extracellularly-bound fluorescence 
(Figure 5c) after a single washing step and hence the unique mode of action of this polymer is 
purely extracellular, although not through ice interactions, unlike previous polymer 
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cryoprotectants.28,48 It is extremely beneficial that the polymer appears to be removed by simple 
washing, rather than multiple washings and/or equilibrations required for DMSO or glycerol 
(for RBCs), which is a major issue in the logistics of cell-based therapies.  
 
Figure 5. Post-thaw growth and polymer interaction. a) Post-thaw cell proliferation for 6 
d, cells were seeded at 1.25∙104 cells per well. b) LIVE/DEAD staining of A549 cells, 24 h 
post-thaw after cryopreservation using indicated cryoprotectants. Scale bar = 50 µm. c) 
Confocal fluorescence microscopy of A549 cells incubated with 10% DMSO or P2 (with no 
DMSO) for indicated time and concentration. Nuclei are stained with DAPI, and incubated 
with P2 tagged with rhodamine 6G, which is green fluorescent. Scale bar = 10 µm. 
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To further probe the impact of the polymers on membrane integrity, a membrane flux assay 
was modified from Su et al.35 A549 cells were loaded with calcein-AM and the quencher trypan 
blue was exogenously added, allowing membrane flux to be continuously monitored by a 
reduction in calcein-associated fluorescence (Figure 6a). DMSO at 20 wt % (above 
cryopreservation levels as a positive control) led to significantly more calcein loss compared 
to other solutions, while DMSO at 10 wt % showed no reduction in flux, supporting the 
hypothesis that 10 wt % thins membranes while 20 wt % promotes pore formation,54 yet it still 
remains that 10 wt % DMSO reduces cell metabolism after only 30 min at RT (Figure S8). 
However, all other formulations did not dramatically change the rate of flux and P2 even lead 
to small reduction in flux rate at higher concentrations, supporting the membrane stabilisation 
hypothesis. Under identical conditions, the LIVE/DEAD stain was again applied to A549 
monolayers (not frozen). After 24 h with P2, there were no significant changes in red nuclei at 
5 mg.mL-1 and only a small increase at 10 mg.mL-1 (Figure 6c), but these time periods are far 
longer than our actual exposure time of 10 min (which is used in the pre-cryopreservation 
incubation protocol). Taken together this data supports a mechanism of external polymer 
membrane integrity stabilisation during the freezing process that enables cells to recover and 
proliferate faster.  
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Figure 6. Impact of polymer on membrane flux and permeability. a) Graphical depiction 
of dye leakage assay. b) Continuous live cell dye leakage assay from calcein-AM loaded A549 
cells treated with varying concentrations of P2. Decreasing fluorescence corresponds to 
increased membrane flux. b) LIVE/DEAD staining of A549 cells after 24 h incubation with 
P2. Scale bar = 50 µm. 
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Discussion 
The cryopreservation of cells is an incredibly complex process where biochemical, as well as 
mechanical and physical factors, govern both the total cell recovery and the retention of 
function/viability. The recovery of large numbers of cells, with retention of function, is 
essential in cell-based therapies (to ensure therapeutic outcome) and in basic biomedical 
research (where cell-studies guide new treatments and understanding). Here we introduce a 
unique macromolecular cryopreservative which enables cells to be frozen in a monolayer 
format with high recovery, allows a reduction in the concentration of DMSO required for 
suspension and monolayer cell cryopreservation, increases the viability of recovered cells, and 
reduces the extent of membrane damage. This macromolecular cryopreservative, a 
poly(ampholyte), was obtained in a single step from a clinically used commodity bulk polymer 
in quantitative yield. Previous reports of polymer cryopreservatives have focused on materials 
which can mimic antifreeze proteins55,56 by controlling ice crystal formation and/or growth, 
which benefits cell cryopreservation.28  The poly(ampholyte) we introduce here had very 
moderate effects on ice crystal growth, but lead to remarkable increases in post-thaw viability 
of over 400 % compared to DMSO alone for cell monolayers and allowed [DMSO] to be 
reduced to just 2 % in some cases. It was found that an 80 kDa polymer weight was optimal 
(P2), although all molecular weights were extremely potent. Mechanistic studies showed that 
this polymer does not enter the cells and appears to function at the membrane, stabilising it 
during freezing but without promoting pore formation or affecting the intrinsic membrane flux. 
This is supported by erythrocyte (red blood cell) studies, which are a useful model for 
membrane damage/stabilisation as well as a crucial component of modern medicine. Utilizing 
the optimal polymer, > 80 % post-thaw recovery of RBCs was possible using the polymer 
alone, with no additional solvents, comparable to the gold standard of glycerol,44 but with the 
advantage of less processing challenges and easy removal, as it is not cell permeable. Taken 
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together, this data supports a mechanism where this new macromolecular cryoprotectant 
appears to stabilise cell membranes against cooling without affecting flux inside to outside the 
cell, enabling faster post-thaw recovery with more intact membranes, and fast proliferation 
rates. Increasing cell yields will speed up biomedical research (by reducing thaw to assay time), 
as well as decrease the number of donor cells required for cell-based therapies by ensuring 
higher recovery from the critical step of cryopreservation. Simpler and/or more effective 
cryopreservatives may also improve the cold chain, leading to reductions in cost associated 
with cell based therapies and regenerative medicine. 
 
Conclusion 
We have shown our potent and easily scalable regio-regular poly(ampholyte) significantly 
improves post-thaw cell recoveries of up to 88 % for adherent cell monolayers compared to 
just 24 % using conventional DMSO cryopreservation. The poly(ampholyte) also enables 
reduction of [DMSO] from 10 wt % to just 2.5 wt % in suspension cryopreservation with 
comparable outcomes, which can enable the preservation of DMSO-intolerant cell lines. We 
have also shown that this polymer leads to cells with reduced membrane damage, faster post-
thaw growth rates, and can additionally cryopreserve red blood cells. Our polyampholyte 
appears to function extracellularly and is thus non-penetrating and easily removed. This new 
polyampholytic cryoprotectant will improve applications across basic and translational 
biomedical science and may drastically enhance the cold-chain processes for biological 
materials. 
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